Effect of cartilage oligomeric matrix protein angiopoietin-1 on peripheral nerves in db/db diabetic mice

Current Therapeutic Research - Clinical and Experimental

Volumn 69, Issue 4, 2008, Pages 343-355

  Jin, Heung Yong ^a   Piao, Ming Han ^a   Park, Ji Hyun ^a   Baek, Hong Sun ^a   Lee, Sik ^b   Kim, Won ^b   Park, Sung Kwang ^b   Kim, Chong Hwa ^c   Koh, Gou Young ^d   Park, Tae Sun ^a  

^a Department of Internal Medicine   (South Korea)

^b Research Institute of Clinical Medicine   (South Korea)

^c Sejong General Hospital   (South Korea)

^d Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

COMP angiopoietin 1; db db diabetic mice; peripheral neuropathy

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 1; BETA GALACTOSIDASE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CAPILLARY DENSITY; CONTROLLED STUDY; DB/DB DIABETIC MOUSE; DIABETIC NEUROPATHY; DRUG EFFECT; FOOD INTAKE; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SKIN NERVE; TREATMENT DURATION;

EID: 51049105245     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2008.08.002     Document Type: Article

References (31)

1. Boulton A.J. The diabetic foot: From art to science. The 18th Camillo Golgi lecture. Diabetologia 47 (2004) 1343-1353
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122 (1995) 561-568
3. Tesfaye S., Stevens L.K., Stephenson J.M., et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: The EURODIAB IDDM Complications Study. Diabetologia 39 (1996) 1377-1384
4. Wang Y., Schmeichel A.M., Iida H., et al. Enhanced inflammatory response via activation of NF-kappaβ in acute experimental diabetic neuropathy subjected to ischemia-reperfusion injury. J Neurol Sci 247 (2006) 47-52
5. Goss J.R., Goins W.F., Lacomis D., et al. Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes 51 (2002) 2227-2232
6. Suri C., McClain J., Thurston G., et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 282 (1998) 468-471
7. Cho C.H., Kammerer R.A., Lee H.J., et al. COMP-Angl: A designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci U S A 101 (2004) 5547-5552
8. Cho C.H., Kammerer R.A., Lee H.J., et al. Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc Natl Acad Sci U S A 101 (2004) 5553-5558
9. Cho C.H., Kim K.E., Byun J., et al. Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ Res 8 (2005) 86-94 [published correction appears in
10. Cho C.H., Kim K.E., Byun J., et al. Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ Res. 98 (2006) e69 ]
11. Lee S., Kim W., Moon S.O., et al. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol Dial Transplant 22 (2007) 396-408
12. Vinik A.I., Park T.S., Stansberry K.B., and Pittenger G.L. Diabetic neuropathies. Diabetologia 43 (2000) 957-973
13. Boulton A.J., Vinik A.I., Arezzo J.C., et al., American Diabetes Association. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 28 (2005) 956-962
14. Siemionow M., and Demir Y. Diabetic neuropathy: Pathogenesis and treatment. J Reconstr Microsurg 20 (2004) 241-252
15. Dyck P.J., Davies J.L., Wilson D.M., et al. Risk factors for severity of diabetic polyneuropathy: Intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 22 (1999) 1479-1486
16. Dyck P.J., Zimmerman B.R., Vilen T.H., et al. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 319 (1988) 542-548
17. Nishikawa T., Edelstein D., Du X.L., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
18. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
19. Tomlinson D.R., Willars G.B., and Carrington A.L. Aldose reductase inhibitors and diabetic complications. Pharmacol Ther 54 (1992) 151-194
20. Yagihashi S., Kamijo M., Baba M., et al. Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41 (1992) 47-52
21. Nakamura J., Kato K., Hamada Y., et al. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes 48 (1999) 2090-2095
22. Vincent A.M., Russell J.W., Low P., and Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25 (2004) 612-628
23. Cameron N.E., and Cotter M.A. Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J Clin Invest 96 (1995) 1159-1163
24. Suri C., Jones P.F., Patan S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
25. Schmelzer J.D., Zochodne D.W., and Low P.A. Ischemic and reperfusion injury of rat peripheral nerve. Proc Natl Acad Sci U S A 86 (1989) 1639-1642
26. Kurose I., and Granger D.N. Evidence implicating xanthine oxidase and neutrophils in reperfusion-induced microvascular dysfunction. Ann N Y Acad Sci 723 (1994) 158-179
27. Kim W., Moon S.O., Lee S.Y., et al. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J Am Soc Nephrol 17 (2006) 2474-2483
28. Kim I., Moon S.O., Park S.K., et al. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Cin Res 89 (2001) 477-479
29. Nakae M., Kamiya H., Naruse K., et al. Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes 55 (2006) 1470-1477
30. Schratzberger P., Walter D.H., Rittig K., et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest 107 (2001) 1083-1092
31. Kato N., Nemoto K., Nakanishi K., et al. Nonviral gene transfer of human hepatocyte growth factor improves streptozotocin-induced diabetic neuropathy in rats. Diabetes 54 (2005) 846-854